Nachrichten zur Assembly Biosciences Aktie

Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 19

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Shares Gain After Promising Early Cut Data From HBV Infection Programs

Assembly Biosciences Inc (NASDAQ: ASMB) announced interim efficacy, safety, and pharmacokinetic (PK) results from a Phase 1b study of ABI-H3733 (3733)…

Assembly Biosciences surges 19% on positive data from two trials to treat hepatitis B virus

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K ASSEMBLY BIOSCIENCES, For: Dec 06

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Presents New Data at AASLD The Liver Meeting® Highlighting Breadth of Virology Portfolio and Potential of Next-Generation Core Inhibitors in HBV

Data demonstrating nanomolar potency of core inhibitor ABI-4334 to disrupt the hepatitis B virus (HBV) life cycle at multiple points…

Assembly Biosciences downgraded at Truist on trial failure, lack of catalysts

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®

Four poster presentations, including two late breaking, highlight breadth and promise of virology portfolio...…

Form 8-K ASSEMBLY BIOSCIENCES, For: Oct 05

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences CEO John McHutchison to Retire, Succeeded by Jason Okazaki

Assembly Biosciences CEO John McHutchison to Retire, Succeeded by Jason Okazaki...…

Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO and Appoints Current President and COO Jason A. Okazaki as Successor

Dr. McHutchison will continue to provide strategic counsel as board member and chairman of the Science & Technology Committee of…

Insiderhandel: Chief Executive Officer verkauft Aktien von Assembly Biosciences im Wert von 26.200$

Mchutchison, John G. - Vorstand - Tag der Transaktion: 2022-08-08...…

Insiderhandel: Chief Financial Officer verkauft Aktien von Assembly Biosciences im Wert von 4.479$

Samar, Michael P. - Vorstand - Tag der Transaktion: 2022-07-25...…

Arbutus Biopharma, Assembly Biosciences plan to continue their hepatitis B mid-stage trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Announces Program Reprioritization and Organizational Update

- Discontinues clinical development of vebicorvir, Assembly Bios first-generation core inhibitor, based on interim efficacy data from ongoing combination clinical…

Arbutus Biopharma Provides Update on the Phase 2A Combination Trial with AB-729 and a Capsid Inhibitor

Triple combination clinical trial evaluating AB-729, an RNAi therapeutic, vebicorvir, Assembly Biosciences core inhibitor, and nucleos(t)ide analog continues with data…

Assembly Bio Commences Early-Stage Study of Drug to Treat Hepatitis B Viral Infection

Assembly Biosciences, Inc. (NASDAQ: ASMB) today announced Initiation of Phase 1b clinical study of its drug candidate ABI-H3733 for Chronic…

Assembly Biosciences Initiates Phase 1b Clinical Trial Evaluating Next Generation Core Inhibitor ABI-H3733 for the Treatment of Chronic Hepatitis B Virus Infection

SOUTH SAN FRANCISCO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., June 03, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Form 8-K ASSEMBLY BIOSCIENCES, For: May 25

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences GAAP EPS of -$0.48

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 10-Q ASSEMBLY BIOSCIENCES, For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., April 01, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences stock price target cut to $12 from $15 at Truist

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Operating Officer verkauft Aktien von Assembly Biosciences im Wert von 10.363$

Okazaki, Jason A. - Vorstand - Tag der Transaktion: 2022-03-28...…

Assembly Biosciences GAAP EPS of -$3.00 misses by $0.90, revenue of $6.25M beats by $0.09M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences to Present During the SVB Leerink 11th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Form 8-K ASSEMBLY BIOSCIENCES, For: Feb 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences Announces Presentation During the 2022 H.C. Wainwright BIOCONNECT Virtual Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Dec. 03, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences (ASMB) Investor Presentation - Slideshow

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Assembly Biosciences Abstracts Selected for Presentation at the Upcoming AASLD The Liver Meeting®

HBV core inhibitor data will be highlighted in one oral and two poster presentations, including one late breaking HBV core…

Assembly Biosciences and Antios ink clinical collaboration agreement

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Antios Therapeutics and Assembly Biosciences Announce Clinical Collaboration Agreement to Evaluate the Combination of ATI-2173 and Vebicorvir in Patients with Chronic Hepatitis B Virus Infection

MENDHAM, N.J., and SOUTH SAN FRANCISCO, Calif., Oct. 19, 2021 /PRNewswire/ -- Antios Therapeutics, Inc. and Assembly Biosciences, Inc. (Nasdaq:…

Assembly Bio Announces October Conference Participation

SOUTH SAN FRANCISCO, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology…

Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge

Midway through trading Thursday, the Dow traded up 0.42% to 35,461.47 while the NASDAQ rose 0.39% to 15,369.38. The S&P…

Assembly Biosciences Shares Drop After Discontinuing Development of a Treatment

Assembly Biosciences Shares Drop After Discontinuing Development of a Treatment...…

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

Heres a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week…